Release Date: August 3, 2023
Expiration Date: August 3, 2024
Activity Overview
This educational activity is an archive of the live presentation held from July 27 to July 29, 2023.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of lung cancer are invited to participate.
Learning Objectives
At the conclusion of this activity, you should be better prepared to:
- Explain biomarkers and testing strategies to optimize selection of therapy in patients with thoracic malignancies
- Discuss emerging evidence concerning the management of patients with nonmetastatic lung cancer
- Apply recent clinical data on single-agent and combination immunotherapeutic approaches to care for patients with advanced thoracic malignancies
- Review recent data sets on targeted and cytotoxic strategies for the management of patients with thoracic malignancies
- Summarize optimal and personalized strategies for sequencing therapy utilizing clinical trial evidence, performance status, and tumor characteristics
- Describe approaches to address variances in care for patients with thoracic malignancies
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
